Insiders Kronos Bio, Inc.

Equities

KRON

US50107A1043

Real-time Estimate Cboe BZX Other stock markets 07:19:12 14/05/2024 pm IST			5-day change	1st Jan Change
1.035 ^USD	+1.47%		-1.90%	-17.60%

09/05	Earnings Flash (KRON) KRONOS BIO Reports Q1 Revenue $2.52M	MT
09/05	Kronos Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kronos Bio Announces Management Shakeup, 3 Top Managers to Step Down in February	26/01	MT
Kronos Bio, Inc. Announces Executive Changes	25/01	CI
Kronos Bio Insider Bought Shares Worth $1,470,395, According to a Recent SEC Filing	18/11	MT
Kronos Bio Appoints Sandra Gardiner as Interim Chief Financial Officer	18/23/18	MT
Kronos Bio, Inc. Appoints Sandra A. Gardiner as Interim Chief Financial Officer	18/23/18	CI
Kronos Bio, Inc. Appoints Sandra A. Gardiner as Principal Financial Officer and Principal Accounting Officer	18/23/18	CI
Kronos Bio Finance Chief Yasir Al-Wakeel Resigning	17/23/17	MT
Kronos Bio Announces Resignation of Yasir Al-Wakeel as Head of Corporate Development, Effective from September 15, 2023	17/23/17	CI
Kronos Bio Announces Resignation of Yasir Al-Wakeel as Chief Financial Officer, Effective from September 15, 2023	17/23/17	CI
Kronos Bio, Inc. Appoints Marc Besman as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance	06/23/06	CI
Kronos Bio, Inc. Appoints Katherine Vega Stultz as Member of the Audit Committee and of the Compensation Committee of the Board	31/23/31	CI
Kronos Bio, Inc. Appoints Roger Dansey as Member of the Nominating and Corporate Governance Committee of the Board	31/23/31	CI
Kronos Bio, Inc. Announces the Appointment of Roger Dansey to its Board of Directors	25/23/25	CI
Kronos Bio, Inc. Announces Changes to Board of Directors	12/23/12	CI
Kronos Bio, Inc. Announces Resignation of Marianne De Backer from Board of Directors, Effective on June 23, 2023	28/23/28	CI
Kronos Bio, Inc. Announces Resignation of Otello Stampacchia from Board of Directors, Effective March 31, 2023	28/23/28	CI
Marianne De Backer to Resign from Board of Directors of Kronos Bio, Inc	27/23/27	CI
Insider Buy: Kronos Bio	20/22/20	MT
Kronos Bio, Inc. Announces Appointment of Elizabeth Olek as Senior Vice President of Clinical Development	02/22/02	CI
Insider Buy: Allogene Therapeutics	14/22/14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Kronos Bio, Inc.

Equities

KRON

US50107A1043

Insiders

Filters